POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.23.2021, 5:10pm CEST, WHO):   U.S. 122,624    India 31,923    United Kingdom 33,560    Russia 21,438    Turkey 28,168    France 6,400    Iran 17,433    Argentina 1,837    Columbia 1,373    Spain 1,391    Italy 3,963    Indonesia 2,881    Germany 10,696    Mexico 12,521    Philippines 15,592    Ukraine 7,866    Malaysia 14,990    Netherlands 1,935    Iraq 2,906    Japan 2,845    Canada 3,822    Bangladesh 1,144    Thailand 13,256    Israel 5,921    Pakistan 2,333    Romania 7,095    Kazakhstan 2,940    Morocco 1,702    Serbia 7,201    Cuba 7,151    Jordan 1,028    Austria 2,089    Vietnam 11,527    Tunisia 1,696    Greece 2,325    Georgia 1,653    Belarus 1,989    Costa Rica 2,731    Azerbaijan 1,356    Myanmar 1,744    Palestine 1,899    Croatia 1,373    Ireland 1,429    Venezuela 1,060    Lithuania 1,962    South Korea 1,716    Mongolia 3,361    Slovenia 1,186    Moldova 1,371    Bosnia and Herzegovina 1,255    China 51    Singapore 1,457    New Zealand 17    Australia 1,684   

Biologists correct flaw in way bacterial susceptibility to antibiotics is tested

Staff Writer |
When a patient is prescribed the wrong antibiotic to treat a bacterial infection, it's not necessarily the physician who is at fault. The current antibiotic assay—standardized in 1961 by the World Health Organization and used worldwide—is potentially flawed.

Article continues below

So says UC Santa Barbara biologist Michael Mahan, whose lab has developed a new antimicrobial susceptibility test that could transform the way antibiotics are developed, tested and prescribed.

The standard test specifies how well drugs kill bacteria on petri plates containing Mueller-Hinton Broth, a nutrient-rich laboratory medium that fails to reproduce most aspects of a natural infection.

Now, Mahan and colleagues have used a mouse model to demonstrate that a variety of antibiotics work differently against various pathogens when inside the mammalian body. Their findings appear in the journal EBioMedicine.

"The message is simple: Physicians may be relying on the wrong test for identifying antibiotics to treat infections," said Mahan, a professor in UCSB's Department of Molecular, Cellular and Developmental Biology.

"By developing a test that mimics conditions in the body, we have identified antibiotics that effectively treat infections caused by diverse bacteria, including MRSA, the cause of deadly Staphylococcal infections.

"These drugs have been overlooked because they failed the standard tests, despite being inexpensive, nontoxic and available at local pharmacies."

The research has significant implications for public health. If a drug that passed the standard test doesn't work, physicians can now choose a different drug immediately rather than increase the dose of the same drug when patients return—often in worse condition—after an ineffective first course of treatment.

Reliance on the standard test may have contributed to the rise in multidrug-resistant bacteria, Mahan noted, due to the continued prescription of ineffective antibiotics. Further, he added, the standard test may also be slowing the discovery of new antibiotics.

"These 'wonder drugs' may already exist but have been rejected by the standard test and are consequently not used in practice," Mahan said.

The scientists also report a way to "fix" the standard test to better predict how well antibiotics will treat infections: Simply add sodium bicarbonate. More commonly known as baking soda, this chemical is found in abundance in the body, where it helps to maintain precise blood pH.

"Sodium bicarbonate makes the petri plates behave more like the body and increases the test's accuracy for assigning the appropriate antibiotic to treat infections," explained co-lead author Douglas Heithoff, a project scientist at UCSB's Center for Nanomedicine.

Mahan also points out that pharmaceutical companies could benefit from using the revised test to rescreen their collections of purified compounds that have failed the standard test.

"There could be a treasure trove of compounds that have been shelved but could actually be quite effective against antibiotic-resistant strains," he said.

"Things aren't as gloomy as we thought," Mahan added. "We just have to be smart about it and change the way we're using the drugs we already have while we continue to search for new ones."

What to read next

Blood test might predict when antibiotics won't help
Bacteria 'sleep' to survive antibiotic treatments and then attack
NTU scientists discover way to improve effectiveness of antibiotics